MGC Pharma: Pushing the envelope of phytocannabinoid-based research

Home > Media mentions > MGC Pharma: Pushing the envelope of phytocannabinoid-based research

Submitted by Linda McGlone

  • Media Title: Health Europa
  • Media Type: Online
  • Publish Date: 11 April 2019
  • Headline: MGC Pharma: Pushing the envelope of phytocannabinoid-based research
  • Abstract: MGC Pharma has a strong relationship with Epilepsy Action Australia, the country’s peak patient advocacy association. The relationship is varied, including collaboration on research, provision of information to patients, and more. In 2019, MGC Pharma co-funded the development of C4E (www.c4e.com.au), a platform that collates information about medicinal cannabis for the thousands of patients suffering from epilepsy in Australia.
  • Link: https://www.healtheuropa.eu/phytocannabinoid-based-research/91279